IMCD - IMCD N.V.
AMS
->
Basic Materials
->
Specialty Chemicals
Rotterdam,
Netherlands
Type: Equity
IMCD price evolution
IMCD
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $223.79 | $223.79 | $394.46 | $394.46 |
| Short term investments | ||||
| Net receivables | $915 | $915 | $714.85 | $714.85 |
| Inventory | $642.46 | $642.46 | $581.48 | $581.48 |
| Total current assets | $1781.24 | $1781.24 | $1707.96 | $1707.96 |
| Long term investments | $9.68 | $9.68 | $8.45 | $8.45 |
| Property, plant & equipment | $151.37 | $151.37 | $136.28 | $136.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $4485.91 | $4485.91 | $4154.57 | $4154.57 |
| Current liabilities | ||||
| Accounts payable | $553.69 | $553.69 | $391.23 | $391.23 |
| Deferred revenue | ||||
| Short long term debt | $573.19 | $573.19 | $429.55 | $429.55 |
| Total current liabilities | $1287.4 | $1287.4 | $978.65 | $978.65 |
| Long term debt | $1240.04 | $1240.04 | $1250.47 | $1250.47 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $2734.88 | $2734.88 | $2428.39 | $2428.39 |
| Shareholders' equity | ||||
| Retained earnings | $775.91 | $775.91 | $764.53 | $764.53 |
| Other shareholder equity | -$80.37 | -$80.37 | -$89.56 | -$89.56 |
| Total shareholder equity | $1751.03 | $1751.03 | $1726.18 | $1726.18 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $394.46 | $222 | $177.88 | $169.01 |
| Short term investments | ||||
| Net receivables | $714.85 | $702.27 | $619.46 | $464.43 |
| Inventory | $581.48 | $622.1 | $526.3 | $371.24 |
| Total current assets | $1707.96 | $1546.38 | $1323.64 | $1004.68 |
| Long term investments | $8.45 | $7.09 | $5.49 | $5.33 |
| Property, plant & equipment | $136.28 | $113.33 | $97.93 | $94.95 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $4154.57 | $3643.51 | $3270.56 | $2710.15 |
| Current liabilities | ||||
| Accounts payable | $391.23 | $389.02 | $403.01 | $291.84 |
| Deferred revenue | ||||
| Short long term debt | $429.55 | $336.04 | $417.44 | $318.94 |
| Total current liabilities | $978.65 | $890.32 | $984.35 | $713.47 |
| Long term debt | $1250.47 | $660.65 | $390.24 | $394.33 |
| Total noncurrent liabilities | $394.33 | |||
| Total debt | ||||
| Total liabilities | $2428.39 | $1971.55 | $1810.73 | $1452.3 |
| Shareholders' equity | ||||
| Retained earnings | $764.53 | $683.96 | $459.83 | $315.72 |
| Other shareholder equity | -$89.56 | -$58.97 | -$58.38 | -$114.53 |
| Total shareholder equity | $1726.18 | $1673.42 | $1459.83 | $1257.85 |
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1196.86 | $1082.42 | ||
| Cost of revenue | $889.04 | $807.72 | ||
| Gross Profit | $307.82 | $274.7 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $134.49 | $123.62 | ||
| Total operating expenses | $1086.52 | $985.31 | ||
| Operating income | $110.34 | $97.1 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $26.09 | $25.18 | ||
| Interest expense | -$17.13 | -$15.17 | ||
| Net income | ||||
| Net income | $70.63 | $69.79 | ||
| Income (for common shares) | $70.63 | $69.79 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4462.97 | $4622.02 | $3435.25 | $2774.92 |
| Cost of revenue | $3320.07 | $3454.34 | $2700.81 | $2209.36 |
| Gross Profit | $1142.9 | $1167.68 | $734.44 | $565.56 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $490.58 | $483.35 | $291.33 | $261.07 |
| Total operating expenses | $4029.87 | $4143.02 | $3129.78 | $2583.13 |
| Operating income | $433.1 | $479 | $305.46 | $191.79 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $110.85 | $122.85 | $76.59 | $44.77 |
| Interest expense | -$49.58 | -$27.3 | ||
| Net income | ||||
| Net income | $292.27 | $313.08 | $207.28 | $120.92 |
| Income (for common shares) | $292.27 | $313.08 | $207.28 | $120.92 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $70.63 | $70.63 | $69.79 | $69.79 |
| Operating activities | ||||
| Depreciation | $9.89 | $9.89 | $8.91 | $8.91 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $73.34 | $124.05 | $124.05 | |
| Investing activities | ||||
| Capital expenditures | -$3.12 | -$3.12 | -$8.33 | -$8.33 |
| Investments | ||||
| Total cash flows from investing | -$130.42 | -$130.42 | -$107.55 | -$107.55 |
| Financing activities | ||||
| Dividends paid | -$63.83 | -$63.83 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $40.38 | $40.38 | $103.98 | $103.98 |
| Total cash flows from financing | -$25.42 | -$25.42 | $102.61 | $102.61 |
| Effect of exchange rate | -$4.35 | -$4.35 | -$2.6 | -$2.6 |
| Change in cash and equivalents | -$85.34 | -$85.34 | $87.34 | $87.34 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $292.27 | $313.08 | $207.24 | $120.92 |
| Operating activities | ||||
| Depreciation | $33.29 | $27.4 | $25.64 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $420.01 | $196.26 | $242.37 | |
| Investing activities | ||||
| Capital expenditures | -$21.24 | -$10.88 | -$18.72 | -$22.32 |
| Investments | ||||
| Total cash flows from investing | -$394.59 | -$196.13 | -$394.3 | |
| Financing activities | ||||
| Dividends paid | -$135.06 | -$58.13 | -$47.33 | |
| Sale and purchase of stock | $392.88 | |||
| Net borrowings | $360.49 | $113.05 | $66.45 | -$103.16 |
| Total cash flows from financing | $216.97 | -$0.02 | $4.73 | $240.37 |
| Effect of exchange rate | -$8.51 | -$8.03 | $4.01 | -$23.78 |
| Change in cash and equivalents | $172.46 | $8.87 | $64.65 | |
News
Fundamentals
| Market cap | $8.00B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 56.95M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 4.37 |
| Book/Share | 32.16 |
| Cash/Share | 3.93 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.41 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.38 |
| Quick ratio | 0.88 |